Stage iv squamous cell carcinoma of the nasopharynx Trials in Chicago, United States

Stage iv squamous cell carcinoma of the nasopharynx has been the subject of sustained clinical investigation across multiple research sites.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT00081211	Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck	TERMINATED	PHASE1
NCT00387335	Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer	COMPLETED	PHASE2
NCT01816984	PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer	COMPLETED	PHASE1/PHASE2
NCT00098631	Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer	COMPLETED	PHASE2
NCT00055913	Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer	COMPLETED	PHASE1/PHASE2
NCT00023959	Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer	COMPLETED	PHASE1
NCT00063895	Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	COMPLETED	PHASE1/PHASE2
NCT00906360	Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck	TERMINATED	PHASE1
NCT01249443	Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection	TERMINATED	PHASE1
NCT00030498	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	COMPLETED	PHASE1